Mechanism of action of nikkomycin and the peptide transport system of Candida albicans. by McCarthy, P, Troke, P, Gull, K

Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy by Smith, DA, Bradshaw, D, Mbisa, J, Manso, CF, Bibby, D, Singer, J, Thomson, E, Filipe, A, Aranday-Cortes, E, Ansari, MA, Brown, A, Hudson, E, Benselin, J, Healy, B, Troke, P, McLauchlan, J, Barnes, E, Irving, WL

Interferon lambda 4 impacts the genetic diversity of hepatitis C virus by Ansari, M, Aranday-Cortes, E, Ip, C, Da Silva Filipe, A, Lau, S, Bamford, C, Bonsall, D, Trebes, A, Piazza, P, Sreenu, V, Cowton, V, Stop-Hcv Consortium, Ball, J, Barnes, E, Burgess, G, Cooke, G, Dillon, J, Foster, G, Gore, C, Guha, N, Halford, R, Holmes, C, Hudson, E, Hutchinson, S, Irving, W, Khakoo, S, Klenerman, P, Martin, N, Mbisa, T, McKeating, J, McLauchlan, J, Miners, A, Murray, A, Shaw, P, Simmonds, P, Smith, S, Spencer, C, Thomson, E, Troke, P, Vickerman, P, Zitzmann, N, Hudson, E, Bowden, R, Patel, A, Foster, G, Irving, W, Agarwal, K, Thomson, E, Simmonds, P, Klenerman, P, Holmes, C, Barnes, E, Spencer, C, McLauchlan, J, Pedergnana, V